Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Vitamin D and the body's anti-inflammatory response in gum disease

Official title: The Effect of Vitamin D Levels and Supplementation on Anti-inflammatory Response in Periodontal Disease: a Randomized Controlled Clinical Trial

Run by Recep Tayyip Erdogan University Training and Research Hospital · NCT07636733 · Data updated 2026-11-12

This study tests whether vitamin D can modulate the body's anti-inflammatory response in people with gum disease.

More Periodontal Diseases trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment120 (estimated)
SponsorRecep Tayyip Erdogan University Training and Research Hospital
Academic / other
Locations1 site (Rize)
StatusRecruiting
StartedJune 3, 2026
Main results expectedOctober 15, 2026
Study endsOctober 16, 2026
Registry record updatedJune 10, 2026
Trial IDNCT07636733 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with periodontal disease or gingivitis who are vitamin D deficient and meet the study’s periodontal criteria.

Probably not a fit

Patients without vitamin D deficiency or those not showing inflammatory alterations may not experience a clear benefit from supplementation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates the anti-inflammatory effects of vitamin D supplementation in individuals with periodontal diseases, including gingivitis and periodontitis, who are vitamin D deficient. Researchers will measure inflammatory and bone-related biomarkers in serum and periodontal tissue to see if vitamin D changes these markers when combined with non-surgical periodontal treatment and oral health education. The trial will enroll about 120 systemically healthy participants and randomize them to receive vitamin D alongside standard periodontal care or standard care alone. Outcomes focus on inflammatory pathways and bone metabolism markers to understand vitamin D’s potential role in periodontal health. The study aims to clarify whether correcting vitamin D deficiency helps reduce gum inflammation and supports periodontal treatment outcomes.

Why it matters

Potential benefit: If successful, vitamin D supplementation could become a supportive option to help reduce gum inflammation and improve periodontal treatment responses.

How similar studies have gone: There are limited studies on anti-inflammatory effects of vitamin D in periodontal disease, making this approach relatively novel but grounded in vitamin D biology.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Study groups will be formed according to the 2017 Periodontal Disease Classification. Accordingly:
* Periodontally healthy; absence of bleeding on probing, erythema, edema, patient symptoms, attachment, and bone loss
* Gingivitis; patients with an average gingival index ≥0.5 according to Löe and Silness
* Stage I-II periodontitis; patients with CAL 1-2 or 3-4 mm and a maximum PPD ≤5 mm, showing radiographic horizontal bone loss up to the coronal third of the root (15%-33%), but without tooth loss due to periodontitis
* Stage III-IV periodontitis; Stage 3 and 4 patients with ≥15 teeth in their mouth, with CAL ≥5 and PPD ≥6 in at least 6 areas, and radiographic bone loss extending to the middle or apical third of the root.

Exclusion Criteria:

* Individuals who have undergone periodontal treatment in the last 6 months, have systemic diseases (such as diabetes, parathyroid and thyroid-related endocrine diseases) that may affect periodontal status, patients with chronic liver disease, hypoparathyroidism and renal failure, those who have been using medications that may affect periodontal response (aspirin, non-steroidal anti-inflammatory drugs or steroids) for a long time, those who are using additional vitamin D or calcium supplements in the pre-study phase, those who are pregnant or breastfeeding, and those with hypercalcemia and malabsorption syndrome will not be included in the study.

Where it's running

  • Recep Tayyip Erdoğan University
    Rize, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.